To evaluate the usefulness of multiple measures from rest and exercise radionuclide angiography (RNA) in predicting cardiovascular death and cardiovascular events (death or nonfatal myocardial infarction) and to assess the prognostic usefulness of the RNA relative to clinical and catheterization data, we studied 571 stable patients with symptomatic coronary artery disease who had upright rest/exercise first-pass RNA within 3 months of catheterization and were medically treated. With a median follow-up of 5.4 years, 90 patients have died from cardiovascular causes, and 147 patients have either died or suffered a nonfatal myocardial infarction. Using the Cox regression model and a preselected group of RNA variables, the most important RNA predictor of mortality was exercise ejection fraction (X2=81, p<0.00001).
To evaluate the usefulness of multiple measures from rest and exercise radionuclide angiography (RNA) in predicting cardiovascular death and cardiovascular events (death or nonfatal myocardial infarction) and to assess the prognostic usefulness of the RNA relative to clinical and catheterization data, we studied 571 stable patients with symptomatic coronary artery disease who had upright rest/exercise first-pass RNA within 3 months of catheterization and were medically treated. With a median follow-up of 5.4 years, 90 patients have died from cardiovascular causes, and 147 patients have either died or suffered a nonfatal myocardial infarction. Using the Cox regression model and a preselected group of RNA variables, the most important RNA predictor of mortality was exercise ejection fraction (X2=81, p<0.00001).
Neither rest ejection fraction nor the change in ejection fraction from rest to exercise contributed additional predictive information. Two other RNA study variables, the change in heart rate from rest to exercise and rest end-diastolic volume index, did contribute additional prognostic information to the exercise ejection fraction (X2=23, p<0.0001). Compared with noninvasive clinical data (history, physical examination, electrocardiogram, and chest radiograph), RNA variables were considerably more predictive of mortality (X2=71 [clinical variables] versus X2=lO4 [RNA] ). Remarkably, the strength of the relation of RNA variables with mortality was equivalent to that of the set of catheterization variables previously demonstrated in our large angiographic population to be prognostically important (x2=104 [RNA] versus X2=102 [catheterization variables]). The RNA contained 84% of the information provided by clinical and catheterization descriptors combined. Furthermore, the RNA contributed significant additional prognostic information to the clinical and catheterization data (x2= 13.6, p=0.0035). For cardiovascular events, the relative prognostic usefulness of the RNA was similar, although relations with this outcome were generally weaker. Descriptors from the rest/exercise RNA exhibit a powerful relation with long-term outcomes and can be useful in defining risk, even when clinical and catheterization data are available. (Circulation 1990 ;82:1705-1717) D a ata have accumulated for more than a decade on radionuclide angiography (RNA) performed with the patient at rest and during exercise, and the diagnostic usefulness of RNA for assessing the likelihood of coronary artery disease (CAD) or anatomically severe disease has experiencing future cardiac events. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Since left ventricular (LV) function is a primary factor affecting prognosis in coronary disease, we would expect measures of LV function from the RNA to be helpful in predicting future cardiovascular (CV) events in patients with CAD. Earlier studies based on relatively small numbers of outcome events identified a strong relation between exercise RNA ejection fraction (EF) and subsequent CV outcomes.812 The prognostic significance of rest RNA EF has also been noted,1213 and other selected RNA variables have been examined for their prognostic relations. [8] [9] [10] [11] [12] [13] [14] [15] From a clinical perspective, it is important to know not only how much prognostic information the RNA contains by itself but also how its predictive value compares with other sources of patient descriptors and whether it adds useful prognostic information to data that may already be available to a clinician when the RNA is ordered. The ability to evaluate the independent contribution to prognosis of multiple RNA variables and to assess the prognostic usefulness of RNA descriptors relative to clinical and catheterization data has been limited by insufficient outcome events, particularly mortality, in a series of patients undergoing both RNA and cardiac catheterization. To date, therefore, the added prognostic value of RNA in patients who have undergone catheterization and have known coronary anatomy has not been adequately defined.
The purpose of this investigation was to comprehensively evaluate the role of RNA relative to clinical and catheterization data in predicting CV death and CV events (death or nonfatal myocardial infarction [MI]) in a large consecutive series of symptomatic, medically treated patients with CAD who underwent rest and exercise RNA studies and cardiac catheterization during an 8-year period at Duke University Medical Center. Our underlying hypotheses were that measures of LV function from the RNA, particularly descriptors of exercise function, would exhibit strong relations with long-term outcomes, compare favorably with other established prognostic indicators, and contribute added predictive information to clinical and catheterization data.
Methods

Study Population
Since January 1977, all patients undergoing RNA and coronary arteriography at Duke University Medical Center have had study results prospectively entered into the Duke Cardiovascular Disease Database.'8 The patient population for this report consisted of 571 consecutive patients who underwent cardiac catheterization for symptoms of CAD between January 1977 and January 1985, who had upright rest and exercise RNA within 3 months of cardiac catheterization, and who were medically treated. Only patients with significant CAD (.75%
luminal diameter narrowing of a major coronary artery'9 were included. Patients were excluded who had a prior revascularization (either surgery or angioplasty), congenital heart disease, or coexistent valvular heart disease, including severe (3+ or 4+) mitral regurgitation. There were 459 men (80%) and 112 women (20%) in the study population. All patients were medically treated for a period of at least 3 months after cardiac catheterization. Selection of therapy was made by the patient and the patient's physician on the basis of symptoms, coronary anatomy, ventricular function, suitability for revascularization, and the general condition and circumstances of the patient. Medical therapy was tailored for each individual patient but usually consisted of risk factor modification, as well as nitrates, ,8-blockers, and calcium channel blockers individually or in combination at a dosage adequate to relieve angina without inducing intolerable side effects. Of the 571 study patients, 149 (26%) underwent either coronary artery bypass grafting (CABG) (137 patients) or percutaneous transluminal coronary angioplasty (PTCA) (12 patients) after at least 3 months of medical therapy. The median time to treatment crossover for these 149 patients was 2.4 years (range, 3 months to 10 years) after the index catheterization. Only 2% of these revascularization procedures were emergency procedures.
Baseline Clinical Infonmation
Baseline data consisting of multiple descriptors of the history, physical examination, chest radiography, and electrocardiography were collected prospectively for each patient at the time of catheterization. Definitions of clinical variables and important prognostic factors (Table 1 ) in our population of catheterized patients have been published elsewhere.20-25 Radionuclide Angiography Study The methods for performing the RNA studies have been described previously.1226-29 Briefly, studies at rest and peak exercise were performed with the patient sitting erect on a bicycle ergometer (Fitron-Lumex, Inc.). A first-pass technique was employed using a multicrystal gamma camera (System Seventy-Seven, Baird Corp.). For both rest and exercise studies, 15 mCi technetium-99m pertechnetate was injected as a bolus, and counts were obtained at 25-msec intervals for 1 minute. Exercise was begun at a work load of 200 kilopond-meters (kpm)/min, and progressively increased by 100 kpm each minute during which blood pressure and the electrocardiogram were monitored. Exercise was continued until one of the following occurred: 1) achievement of 85% of maximum predicted heart rate (HR), 2) positive electrocardiographic changes (.0.1 mV ST segment displacement from control with an ST segment slope that was horizontal or directed away from the baseline), 3) chest pain to a degree that the attending physician advised termination of exercise, or 4) severe fatigue, dyspnea, or arrhythmias. Whenever possible, cardiac medications, including a-blockers, were discontinued 48 hours before study. All RNA data were processed using software developed at our institution.27,28 8 ECG, electrocardiographic; PVCs, premature ventricular contractions; LBBB, left bundle branch block; RBBB, right bundle branch block; IVCD, intraventricular conduction disturbance; LAD, left anterior descending.
Entries are percentages except for continuous variables, when the median is reported followed in parentheses by the 25th and 75th percentiles.
*For prognostic modeling involving clinical characteristics, these variables were grouped together in a clinical index.
tlncluded as a clinical variable only in analyses involving event-free survival.
Preselected RNA variables considered in this study ( Table 2 ) included rest and exercise assessments of EF (expressed as percent), HR, wall motion abnormalities, blood pressure (BP), end-systolic and end-diastolic volume indexes (ESVI and EDVI), double product (HRx systolic BP), and LV "contractility" index30,31 (systolic BP/end-systolic volume). Also included were variables reflecting exerciseinduced abnormalities (e.g., chest pain, wall motion abnormalities, positive electrocardiographic changes), variables reflecting the change from rest to exercise (exercise minus rest) in EF (A EF) and HR (A HR), and, finally, the duration of exercise. Validation studies for RNA EF and volume measurements at our institution, including interobserver variability at rest and exercise, have been published previously.26,28 EDVI and ESVI were determined by dividing the respective volumes by body surface area. The wall motion assessment was derived from the consensus of at least three experienced observers who had no knowledge of the patient's clinical or catheterization data. 30 Positive exercise ECG 27 WM, wall motion; ECG, electrocardiogram.
*Systolic blood pressure/end-systolic volume.
tHeart ratexsystolic blood pressure.
Cardiac Catheterization
Selective coronary angiograms were recorded in multiple left anterior oblique and right anterior oblique projections, and biplane left ventriculography was performed. A detailed representation of the coronary anatomy was completed on each patient, including location and degree of narrowing for each lesion. Significant stenosis was defined as 75% or greater obstruction of a major coronary artery.t9
Angiograms were generally interpreted in conference by at least two experienced angiographers. The coronary angiographic methods have been validated in a previous angiographic/pathological study, and the interobserver variability has been demonstrated to be small.32 Angiographic LV EF was calculated using the modified area-length method.33 Follow-up Data Follow-up information concerning death and nonfatal MI was obtained prospectively by mailed questionnaire or telephone interview at 6 months, 1 year, and yearly intervals thereafter, as described previous-ly. [20] [21] [22] Considering all intervals, follow-up was 98% complete. Deaths were classified by a review committee without knowledge of the patient's clinical, catheterization, or RNA data. Criteria used to diagnose follow-up MI and validation of the accuracy of our follow-up procedures for detecting nonfatal MI have been described previously.21t22
Statistics
Baseline characteristics of the study patients were described in terms of percentages for categorical variables and by the median, 25th, and 75th percentiles for continuous variables. Cumulative survival rates as a function of time after cardiac catheterization were calculated using the Kaplan-Meier method.34 Follow-up time of patients undergoing CABG or PTCA after at least 3 months of medical therapy was included up to the date of their revascularization; these patients were then censored (withdrawn alive) from the survival calculations.
The Cox proportional hazards regression model35,36 was used for examining individual as well as joint relations between RNA variables and patient outcomes. Outcomes of interest included CV death and total cardiac events (CV death or nonfatal MI). With the Cox model, we first examined the shape and strength of the relation between individual RNA variables and time until the occurrence of these outcomes through the use of a flexible model-fitting approach involving spline functions (cubic polynomials).37-41 These functions were graphically examined to assess the implicit assumption with this regression model that patient characteristics are linearly related to the logarithm of the hazard ratio. 35 Determining how variables should be modeled was an important step in characterizing prognostic relations and identifying which variables were most strongly related to subsequent outcomes.41 Next, several specific hypotheses concerning RNA variables, motivated by our previous study,8 were tested using the Cox model. By examining EF variables individually and in combination, we tested whether exercise EF was a more important predictor of CV outcomes than either rest EF or A EF and whether rest EF or A EF added any prognostic information to that provided by exercise EF. Finally, multiple RNA variables were fitted in a stepwise fashion to determine which variables contained independent prognostic information about the likelihood of future events. We also examined whether the prognostic relation of any important variable differed for particular levels of other important descriptors (i.e., we tested for "interactions" among important RNA variables).
Clinical and catheterization variables (Table 1 ) previously demonstrated to be prognostically impor-tant20,2123,25 were examined with the Cox model to assess the relative prognostic information provided by clinical variables alone, by catheterization variables alone, and by clinical and catheterization variables combined, in comparison to prognostic information provided by RNA variables alone. For each group of variables, the likelihood ratio x2 statistic for the overall model containing those variables was used as an index of their total prognostic information.
Clinical and RNA variables were then considered together to contrast the combined prognostic information of noninvasive variables with that of clinical plus catheterization variables. Finally, clinical, catheterization, and RNA variables were considered together in multivariable analysis to examine the extent to which RNA contributed prognostic information beyond that contained in clinical and catheterization data. To effectively model the many clinical descriptors important for describing a patient, variables representing a common clinical phenomenon were grouped together in previously developed indexes23,42 (Table 1) . Specific clinical variables included in the analysis of CV death were age, gender, and indexes of pain/ischemia, myocardial damage, vascular disease, and conduction defects ( Table 1 ). The catheterization variables included LV EF (truncated at 60), number of diseased vessels, maximal percent stenosis of both the left main and proximal left anterior descending arteries, mitral insufficiency, and an interaction between EF and number of diseased vessels. 25 Once the relative importance of each group of variables (clinical, catheterization, and RNA) was established, we also examined the independent contribution to prognosis of individual variables using a stepwise analysis of the combined set of variables that comprised the important predictors from each group. In the absence of an independent test sample in which to fully validate all of the study results, we randomly divided the study population into two groups and examined the replicability of the findings in each subgroup. Cox model analyses were performed using the SAS procedure PHGLM43 and the SAS survival analysis software SRVTREND.37
Results
Baseline Descniption
Prognostic clinical and catheterization characteristics of the 571 study patients are reported in Table 1 . Compared with 1,579 consecutive patients undergoing catheterization at our institution during the same time period and satisfying the same inclusion criteria except that no RNA was performed, the study patients as a group were slightly younger and had lower percentages of unstable or progressive angina, cardiomegaly, electrocardiographic ST and T wave changes, and three-vessel disease. With respect to LV function and other prognostic factors in Table 1 , study patients were similar to the larger population of patients catheterized for symptoms and treated medically for at least three months.
Descriptive summary information from the rest and exercise RNA studies is presented in Table 2 . During exercise, 30% of patients experienced chest pain, 27% had positive electrocardiographic changes, and 37% achieved 85% of their maximal predicted HR.
Outcome Events
Among the 571 study patients, 90 have suffered a CV death. A total of 147 patients have suffered either CV death or nonfatal MI during follow-up (median duration of survival in patients who died, 2.8 years;
median duration of follow-up in surviving patients, 5.4 years). Kaplan-Meier rates (based on CV death) at 3, 5, 7, and 9 years for the overall group were 90%, 87%, 81%, and 73%, respectively. Infarction-free survival rates at the same time points were 83%, 76%, 70%, and 62%, respectively.
Univariable Relations -Importance of Ejection Fraction Measures
Univariable, or unadjusted, associations between RNA variables and the occurrence of future CV outcomes are presented in Table 3 . As reflected in the first column, the strongest RNA predictor of mortality was exercise EF. Strong univariable relations were also exhibited by rest and exercise ESVIs, rest EF, rest and exercise "contractility" indexes, rest and exercise EDVIs, rest and exercise wall motion 70 33 Rest "contractility" index 69 39 Exercise end-systolic volume index 65 40 Exercise "contractility" index 63 35 Rest end-diastolic volume index 60 42 Exercise end-diastolic volume index 39 24 Rest wall motion abnormalities 34 15 A Heart rate 15 9 Exercise wall motion abnormalities 13 7 Rest double product 10 6 Exercise time 8 3 Exercise double product 7 11 Exercise systolic blood pressure 6 4 Rest heart rate 6 1 Exercise heart rate 6 10 A Ejection fraction 5 6 CV, cardiovascular.
abnormalities, and the change in HR with exercise. The strongest predictors of mortality were also the strongest individual predictors of total CV events, although the precise ordering of the variables changed somewhat for this end point. The generally lower x2 statistics in the second column of Table 3 (total events) compared with the first column (CV death) reflect the increased difficulty and greater variability in predicting total CV events. Considering RNA EF variables collectively, exercise EF was only slightly better than rest EF as a univariable predictor of CV mortality (Table 3) . However, exercise function was considerably stronger than rest EF at predicting the occurrence of any CV event. Compared with either rest or exercise EF, A EF was weakly associated with CV outcomes. In a combined analysis of EF measures, neither rest EF (p=0.12 [death] ;p=0.65 [events]) nor A EF (p=0. 27 [death]; p=0.37 [events]) contributed further prognostic information to exercise EF for either CV death or total CV events.
CV Death
Total E
The relation between exercise EF and the hazard (risk) of CV death is depicted in Figure 1 (left panel). For exercise EF of less than 50, the risk of death increases linearly as EF decreases, with the highest risk occurring at the lowest EFs. For exercise EF of more than 50, there is no gradient in CV mortality. A similar relation exists for total events (right panel). Considering the entire range of EF values, the effect of exercise EF on outcome is clearly nonlinear. For rest EF, the prognostic relations are similar to those in Figure 1 except that linearity is exhibited in the range below approximately 60.
The ability of exercise EF to separate patients into different risk strata is illustrated in Figure 2 Figure 3 . The inability of A EF to risk-stratify patients is clearly evident. Furthermore, the absence of a relation between A EF and survival was observed in patients with normal rest EF as well as in patients with abnormal function at rest. In Figure 4 are shown 1-, 3-, 5-, and 7-year survival rates (left panel) and infarction-free survival rates (right panel) as a function of exercise EF. Patients with a depressed exercise EF are considerably more likely to have future cardiac events, particularly a fatal event, compared with patients whose exercise function is normal.
Multivariable Analysis -Radionuclide Angiography Variables
Considering the RNA variables together in multivariable stepwise analysis, three variables (exercise EF, change in HR with exercise, and rest EDVI) provided independent prognostic information for CV death ( Table 4 ). The risk of death associated with a low exercise EF was further increased if the change in HR with exercise was small and the rest EDVI was high. For total CV events, the same three variables contained the important prognostic information (with the minor exception that exercise HR contributed more to the risk of an event than did the change in HR). For either end point, there was no evidence of any significant "interactions" among the indepen-:vents dently important RNA variables (i.e., the prognostic relation of any one of these variables did not vary according to the values of the other two variables). In combination with exercise EF and HR, rest ESVI contributed nearly as much prognostic information as did rest EDVI. In fact, for total CV events, rest ESVI as a single variable exhibited the most significant individual relation (Table 3) . It was replaced, however, by EDVI once the information in exercise EF and HR was considered. In the two randomly divided subsets of the study population, results were very consistent with the overall findings. In each half, the relation of exercise EF with the risk of death was basically identical to that shown in Figure 1 , and the stepwise selection of important RNA variables was consistent with the results above. Multivariable Analysis -Clinical, Catheterization, and Radionuclide Angiography Variables The prognostic importance of RNA variables relative to clinical and catheterization variables is summarized in Table 5 . Cox model x2 statistics in this table represent an index of the total prognostic information provided by each separate group of variables. For CV death, RNA provided prognostic information considerably exceeding that of the clinical variables and even slightly exceeding, although essentially equivalent to, that of the catheterization variables alone. The clinical variables in combination with RNA contained only sightly less information than was provided by the clinical plus catheterization variables. The RNA by itself contained 84% (104 of 124) of the information provided by the combination of clinical and catheterization descriptors. The RNA added a x2 of 13.6 (p=0.0035 based on 3 df) to the combined clinical and catheterization variables, reflecting a significant contribution of prognostic information by the RNA even when clinical and catheterization data are known. For total events, the pattern was similar, although all relations were weaker as reflected by smaller x2 statistics in the third column of Table 5 . Again, the RNA provided prognostic information considerably exceeding that of the clinical variables alone and essentially equivalent to that of the catheterization variables. The RNA contained 80% (66 of 82) of the information provided by the combination of clinical and catheterization descriptors. The RNA added a x2 of 10.8 (p=0.0128 based on 3 df) to the combined clinical and catheterization variables, again reflecting a significant contribution of prognostic information by the RNA beyond that contained in clinical and catheterization data. These results were replicated in the two randomly determined subsets of the study population. For CV death, the RNA added a x2 of 10.5 and 12.7, respectively, to the combined clinical and catheterization variables in the two subgroups and contained 75% and 81%, respectively, of the information provided by the combination of clinical and catheterization descriptors.
To illustrate the added contribution of RNA to clinical and catheterization data for defining patient risk, Figure 5 (left panel) demonstrates how exercise EF further stratifies prognosis in patients with a fixed degree of anatomical disease severity, in this case, three-vessel coronary disease. Kaplan-Meier 3-year survival for patients with three-vessel disease and an exercise EF of less than 30 is only 50% in contrast to 80% or higher in groups with three-vessel disease and higher levels of exercise EF. In Figure 5 (right panel), the catheterization description of the patients is even further specified. For patients with threevessel disease and a catheterization EF equal to or less than 45, survival in the 33 patients with exercise EF of less than 30 is considerably lower than in the 34 patients with higher levels of exercise EF. Exercise EF stratifies prognosis, even when clinical and catheterization variables are known.
Finally, a stepwise analysis to examine the independent contribution to prognosis of the individual vari- ables that comprised the 15 clinical, catheterization, and RNA variables reported in Table 5 produced the results reported in Table 6 . Exercise EF was the most significant predictor of CV death among all the variables considered, followed by number of diseased vessels. Two of the first three prognostic descriptors in this list were variables from the RNA.
Discussion
Extension of Earlier Duke Studies
Results of this study represent a major extension of the prognostic assessment of rest and exercise RNA previously published from this institution.8 The earlier analysis, which involved a smaller study population (386 patients) and considerably fewer outcome events (27 deaths and 45 cardiac events), was important in identifying exercise EF as the RNA variable most strongly associated with future cardiac events. 8 At that time, however, no other RNA descriptors appeared to contribute additional prognostic information because of the limited number of outcome events. Furthermore, the number of events did not permit a comparative assessment of the prognostic usefulness of the RNA relative to clinical and catheterization variables.8 The present study included all 386 patients from the initial cohort and a considerably extended follow-up of those patients. In addition, 185 patients added to the series since the earlier report were also included. This study is the first comprehensive evaluation of RNA relative to clinical and catheterization data for predicting survival and represents the largest patient series with the longest follow-up reported to date.
A major finding of this study is that for predicting outcomes in patients with chronic CAD treated medically, rest and exercise RNA provided prognostic information equivalent in amount to that available from cardiac catheterization alone and provided more than 80% of the prognostic information contained in clinical and catheterization descriptors combined. Furthermore, RNA contributed significant additional prognostic information beyond that contained in the combined clinical and catheterization variables.
Role of Exercise Ejection Fraction
The one best RNA predictor of CV death was exercise EF, confirming the findings of our previous study.8 Furthermore, exercise EF was the most significant predictor of CV death among all noninvasive clinical variables (including the derived clinical indexes) and all invasive catheterization variables that we have previously determined in a large angiographic population to be prognostically important. Exercise EF was also a strong predictor of total CV events (CV death or nonfatal MI). We note that rest EF was a strong univariable predictor of prognosis, containing approximately 86% and 73% of the prognostic value of exercise EF for predicting CV death and total CV events, respectively (see Table 3 ). In multivariable analysis, neither rest EF nor A EF contributed further prognostic information to exercise EF for either CV death or total CV events. This result implies that the most useful information for predicting prognosis is neither the patient's EF before exercising nor the amount by which the EF changes during exercise. Neither the rest EF nor A EF alone adequately describes prognosis for medically treated patients with CAD. The most important information is the absolute level of EF at peak exercise. Thus, for example, a patient whose rest EF of 30% increases with exercise to 35% has a similar prognosis to that of a patient whose rest EF of 50% decreases to 35%. The functional response to exercise describes a better prognosis in the former and a poorer prognosis in the latter patient than would be anticipated from the rest measurement alone. By combining the information from rest EF and the change in EF that occurs with exercise, exercise EF best summarizes the risk of future events for medically treated patients with CAD. Although two patients with equivalent exercise EFs may have a similar prognosis, it is certainly possible that the mechanism of death could be different in the patient whose EF substantially decreases with exercise compared with the patient whose EF increases. Therapeutic approaches to reduce mortality may also be different in these patients. The present study does not address these questions, which are important areas for future investigation.
It is of interest that the change in EF during exercise contained relatively little predictive information. In a previous study of patients with CAD, we observed that the change in EF with exercise was inversely related to the rest EF. 15 Patients with normal or near-normal rest function demonstrated the highest likelihood of decreasing their EF with exercise but conversely demonstrated the lowest mortality. On the other hand, patients with a low rest EF more frequently demonstrated no change or slight increases in EF during exercise but exhibited a high mortality rate. It is not inconsistent that the change in EF with exercise plus the rest measurement (which combined is precisely the exercise EF) provides additional prognostic information compared with rest EF or A EF alone and that A EF is not a strong individual predictor of mortality. In a previous study of RNA in post-MI patients, we found that the change in EF with exercise was related to ischemic events, including refractory angina requiring CABG.9
The association of exercise EF with outcome is not a linear relation (Figure 1 ). Mortality is highest in patients with the lowest exercise EFs, and the risk decreases consistently as exercise EF increases to a level of approximately 50. For exercise EF values of more than 50, there is no further gradient in mortal-ity. The prognostic effect of exercise EF would be improperly quantified and the strength of its relation with survival would be underestimated if this variable was entered in a Cox model analysis in the way that such variables are typically analyzed. (The usual approach assumes the log hazard ratio is a linear function of the variable. 35 If the entire range of exercise EF values was modeled linearly for CV death, its associated x2 would be 66 instead of 81 as reported in Tables 3, 4 , and 6. The model V2 of the three RNA variables in Table 5 would be 93 instead of 104. Thus, how we model these variables makes a difference. Use of spline functions (cubic polynomials)37-41 with the Cox model allowed us to assess the shape of the prognostic relation and accurately assess the relative prognostic value of exercise EF. We note that other RNA variables, in particular, the volume measurements, were also not modeled linearly because of the results of the spline analysis.
Additional perspective as to the prognostic effects of exercise EF relative to the angiographic assessment of disease severity can be obtained from our multivariable analysis by comparing the Cox regression coefficient for exercise EF with the regression coefficient for the number of significantly diseased coronary vessels. For exercise EF in the range below 50, a difference of 13 points is equivalent in its effect on prognosis to one significantly diseased coronary artery. Hence, other things being equal, a patient whose exercise EF is 13 points lower than that of another patient has an increased risk approximately equivalent to that conferred by having one additional major coronary artery with a 75% or greater stenosis.
The observation has previously been made that the change in EF with exercise may require a different interpretation in women than in men.4445 Only 20% of our study patients were women, however, and only 12 deaths have occurred to date among female subjects. It was not possible, therefore, to adequately address in this study whether RNA results should be interpreted for prognostic purposes in the same manner for men as for women.
Cardiovascular Death Versus Cardiovascular Events
Prognostic relations between RNA variables and the occurrence of any CV event (death or nonfatal MI) were qualitatively similar but considerably weaker in this study than the relations with cardiac death. Weaker relations with this composite end point were also apparent for the clinical and catheterization variables. Our inability to predict total events as accurately as death may result because our understanding of the mechanisms that underlie MI is incomplete, and the variables that predict MI may be different from the variables that predict death. Alternatively, nonfatal MI may be predicted by the same variables, but in contrast with death, there is more overlap between patients who do and do not have an MI, and thus we cannot discriminate as well the patients who are likely to have an event. Further study is required to resolve these issues.
Relation With Other Studies
In a study population similar to the patients in this report, Taliercio and coworkers13 at Mayo Clinic found three variables that were independently associated with follow-up cardiac events: number of diseased vessels, RNA rest EF, and age. No exercise RNA variables contributed additional prognostic information to these three factors. The Mayo results differ not only from our present study but also from findings from the National Heart, Lung, and Blood Institute (NHLBI), where medically treated patients with three-vessel disease were stratified into highand low-risk subgroups on the basis of ischemic responses during exercise.1046 There were 16 cardiac deaths and 16 nonfatal MIs in the Mayo study patients13 and five deaths in the NHLBI study,10 thus limiting the ability of either of these studies to reliably detect important relations with CV death.
Several investigators have examined the prognostic value of RNA data obtained early after acute MI.947-58 The published reports vary considerably in the number and type of patients studied, nature of the RNA protocol (including whether exercise studies were performed), length of patient follow-up, variables that were examined, and end points considered. A consistent feature, however, is the conclusion that LV EF is strongly related to prognosis. In studies without an exercise protocol, rest EF was an important predictor of outcome. [53] [54] [55] [56] [57] [58] Where exercise studies were conducted, exercise EF was found to be a significant predictor.9,47-49 Two studies reported that the change in EF during exercise was prognostically important,50,51 whereas in other studies9,52 this was not found to be the case. The prognostic importance of exercise EF in our study is most consistent with the observations reported by Morris and coworkers9 in a population of patients who survived acute MI, had rest and exercise RNA gated equilibrium studies after MI, and were subsequently followed. Exercise EF was the most potent predictor of mortality in that study and contained all of the prognostic information present in rest EF.9 Cautious interpretation of the various post-MI studies is required because of the relatively small number of deaths and the diversity of events considered as outcomes. The usefulness of the RNA relative to angiographic descriptors was not assessed in any of those studies.
Numerous studies have examined the prognostic value of exercise thallium-201 imaging.59-68 In a series of 204 patients who underwent both cardiac catheterization and quantitative exercise '01'f imaging and were followed for 4-9 years, Kaul and coworkers69 reported that information obtained from exercise '01TI imaging was marginally superior to that obtained from cardiac catheterization alone. Of 91 events in their series, however, there were only 20 deaths and 21 nonfatal infarcts. The remaining 50 events were coronary bypass operations more than 3 months after cardiac catheterization. 69 The relatively small number of deaths and the diversity of outcome events are also limiting in many of the prognostic studies of '11 imaging. Although we studied RNA rather than thallium, the prognostic usefulness of an exercise stress imaging modality as defined by our present study appears consistent with the findings of Kaul et al. 69, 70 Limitations There are several limitations inherent in our study. First, the study patients were ambulatory and could undergo exercise testing as part of their clinical evaluation. Furthermore, the patients represent a selected sample of ambulatory patients undergoing cardiac catheterization during an 8-year period at our institution. Compared with 1,579 patients who underwent catheterization but did not have an RNA within 3 months, patients in this study did not appear to be substantially different with respect to baseline clinical and catheterization descriptors. The generalizability of our results to other populations, in particular to patients referred for noninvasive testing who do not undergo cardiac catheterization, is currently under investigation at our institution. Second, in contrast to patients in this study, all of whom received medical treatment for at least 3 months, there was a parallel group of 353 patients who had both RNA and catheterization studies but underwent CABG within 3 months of catheterization and hence were excluded. Compared with the medically treated study patients, surgical patients had more severe anginal symptoms and more extensive anatomical disease but a slightly lesser degree of LV dysfunction. Although selection biases are inherent in nonrandomized assignment of therapy, the medical group reported does represent a broad spectrum of disease severity and RNA test results (Tables 1 and 2 ). EF dropped by 10 or more points with exercise in 27% and 5 or more points in 40% of the study patients. Third, a sizable number (149) of study patients underwent revascularization (CABG or PTCA) after at least 3 months of medical therapy. Because of possible biases introduced by such treatment crossovers, care is required in interpreting and generalizing the prognostic relations observed in this study. Fourth, the catheterization data with which RNA has been compared in this study did not include quantitative angiographic measures of the various coronary lesions or descriptors of plaque morphology. Such descriptors might strengthen the prognostic relations of the catheterization data and their prognostic value relative to RNA. Finally, although the RNA was not routinely used to determine prognosis during the study period, it is possible that in some cases the decision to perform cardiac catheterization was based on results of the RNA.
Conclusions and Clinical Implications
Despite these limitations, strong and consistent evidence is presented that rest/exercise RNA contributes important prognostic information for patients with significant CAD who are treated medically. By characterizing the functional significance of underlying coronary artery stenoses,68 RNA contributes prognostic information beyond that contained in clinical and catheterization variables. The functional and physiological information provided by RNA supplements the anatomical or structural abnormalities determined by coronary arteriography.71 Thus, RNA is useful in defining risk even when both clinical and catheterization data are available.
Our findings may have important implications for the management of patients with CAD. For the noninvasive estimation of CV death or events, clinical variables contained only 59% (71 of 120) and 62% (48 of 78) of the predictive ability of the RNA and clinical variables combined ( Table 5 ). Exercise RNA thus substantially improves outcome estimates based on clinical variables alone. Consequently, abnormal RNA findings may identify patients at increased risk for whom invasive evaluation is indicated. Exercise RNA also improves outcome estimates based on information from the clinical evaluation and cardiac catheterization. Previous studies from our institution and others have demonstrated that the benefit of coronary revascularization in improving survival for patients with CAD depends on the underlying medically treated risk of the patients and their coronary anatomies. 25, 72 Consequently, RNA may also help clarify the potential benefit of coronary revascularization and assist in the selection of patients for revascularization procedures. Although preliminary studies have begun to address this issue,73-75 further investigation is needed.
